Skip to main content
. 2018 Jul 12;29(8):2110–2122. doi: 10.1681/ASN.2017121338

Figure 7.

Figure 7.

Calcineurin inhibitors may ameliorate anillin (ANLN)-mediated disease by targeting ANLN and mTOR expression. (A) Representative Western blot images of ANLN and mTOR protein amounts in GFP control– and VIVIT-expressing podocytes. (B and C) Quantification of Western blots revealed a significant decrease in (B) ANLN and (C) mTOR protein in VIVIT-expressing podocytes compared with GFP control podocytes (P<0.01 and P=0.03, respectively). tGFP, turbo GFP.